About US
Contact us
-
Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNSEmergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million2011/5/30
-
Bayer, Epitomics enter service agreement for antibody technologyEpitomics, Inc. announced today that it has signed a service agreement with Bayer Schering Pharma AG, Germany (Bayer HealthCare). Epitomics will use its proprietary rabbit monoclonal antibody technolo2011/5/27
-
PAREXEL, Pfizer partner to execute clinical development programs on global basisPAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been selected as one of two strategic partners by Pfizer Inc. to pro2011/5/27
-
The revised Provisions for Adverse Drug Reaction Reporting and Monitoring issuedThe newly revised Provisions for Adverse Drug Reaction Reporting and Monitoring was issued on May 24, 2011, and will be put into force on July 1, 2011. The revised Provisions for Adverse Drug Reactio2011/5/26
-
Study shows positive link between percentage of motile sperm and serum vitamin D levelsVitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but no2011/5/26
-
New study finds drug's side effect labeling have ballooned in sizeThe lists of potential side effects that accompany prescription drugs have ballooned in size, averaging 70 reactions per drug, a number that can overwhelm physicians trying to select suitable treatmen2011/5/25
-
Fluorinated glucosamine blocks synthesis of key sugar linked to skin inflammation, cancer progressionCharles J. Dimitroff, MS, PhD and colleagues in the Dimitroff Lab at Brigham and Women's Hospital, have developed a fluorinated analog of glucosamine, which, in a recent study, has been shown to block2011/5/25
-
Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the bodyA little bitter with a little sweet, in the form of a nano-complex dietary supplement taken before meals, can result in a substantial reduction of fat and sugar absorption in the body, Hebrew Universi2011/5/24
-
Long-term, regular acetaminophen use may be associated with lower prostate cancer riskResearchers say too early to justify use to reduce risk, but could provide biological clues A new study from American Cancer Society researchers finds use of 30 tablets a month or more of acetaminoph2011/5/24
-
FDA approves SUTENT for treatment of pancreatic NETPfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pancre2011/5/23